Location History:
- Osaka, JP (1991)
- Takatsuki, JP (1997 - 2006)
Company Filing History:
Years Active: 1991-2006
Title: **Koji Magota: Innovator in Coupling Factor Research**
Introduction
Koji Magota is a notable inventor based in Takatsuki, Japan. With a remarkable portfolio of six patents, Magota has been at the forefront of research in biochemistry and biotechnology, particularly focusing on coupling factors and microbial metabolism.
Latest Patents
Magota's latest inventions include the "Coupling Factor 6 Inhibitor and Potentiator and Use Thereof" and "Methods of Measuring the Presence/Absence of a Coupling Factor 6." These innovative patents detail methods of detecting and quantifying coupling factor 6 in the bloodstream, elucidating its relation to various diseases. Furthermore, the patents propose diagnostic and therapeutic techniques involving the inhibition of this coupling factor, utilizing vectors containing DNA coding for coupling factor 6 and specific antibodies for its assay. Another significant patent addresses a method of culturing microorganisms with a methanol metabolic pathway, aimed at optimizing growth conditions through effective gene expression systems.
Career Highlights
Throughout his career, Magota has worked with prominent companies in the biotechnology sector, including Suntory Limited and Daiichi Suntory Pharma Co., Ltd. His work in these organizations has significantly contributed to advancements in pharmaceutical and biochemical research.
Collaborations
Magota has collaborated with esteemed colleagues such as Yuji Suzuki and Toyofumi Masuda, fostering an environment of innovation and research excellence. These collaborations have played a crucial role in the development of his patents and have enhanced the understanding of complex biochemical processes.
Conclusion
Koji Magota continues to be an influential figure in his field, leveraging his expertise to advance scientific knowledge and contribute to the development of innovative medical diagnostics and treatments. His patents not only reflect his commitment to research but also promise potential breakthroughs in understanding and addressing health-related challenges.